🇺🇸 FDA
Patent

US 9487753

Compositions of adult disc stem cells and methods for the treatment of degenerative disc disease

granted A61KA61K35/12A61K35/32

Quick answer

US patent 9487753 (Compositions of adult disc stem cells and methods for the treatment of degenerative disc disease) held by DiscGenics, Inc. expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DiscGenics, Inc.
Grant date
Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K35/12, A61K35/32, A61P, A61P19/00